4DMedical (ASX:4DX) secured a commercial contract with Utah-based Intermountain Health to implement its pulmonary hypertension analysis product, according to a Monday filing with the Australian bourse.

The pulmonary hypertension analysis product is an artificial-intelligence-based algorithm designed for acute care settings to aid response teams in assessing pulmonary hypertension due to pulmonary embolism, the filing said.

The contract was secured through Microsoft-owned Nuance Communications as part of the company's strategic distribution partnership, according to the filing.

4DMedical shares were up 5% in morning trade on Monday.